Internal Medicine, Cardiovascular Disease · Dekalb, IL
NPI
1891704037
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
5 Kish Hospital Dr Ste 103
Dekalb, IL, 60115
Phone (630) 232-0280
Groups this clinician bills Medicare through
Medicare paid, 2024
$307K
9,588 services
Medicare patients, 2024
3,241
Average age 75
Drug cost, 2024
$1.0M
5,940 prescriptions
Company payments, 2025
$23.74
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jagdish R Patel was code 93010 (electrocardiogram), 5,245 times for 2,471 patients. In total Jagdish R Patel billed 9,588 services in 48 codes, and Medicare paid $307K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-09-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93010 Electrocardiogram | Facility | 5,245 | 2,471 | $6.19 | $32K |
| 93306 Echocardiography (TTE/TEE) | Facility | 772 | 745 | $50.15 | $39K |
| 99233 Hospital E&M - Subsequent | Facility | 771 | 261 | $93.56 | $72K |
| 99214 Office E&M - Established | Office | 609 | 408 | $83.69 | $51K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 383 | 348 | $13.04 | $4,996 |
| 99223 Hospital E&M - Initial | Facility | 324 | 274 | $136.13 | $44K |
| 99213 Office E&M - Established | Office | 255 | 211 | $60.26 | $15K |
| 93018 Electrocardiogram | Facility | 183 | 180 | $9.89 | $1,810 |
| 93016 Electrocardiogram | Facility | 183 | 180 | $15.02 | $2,748 |
| 99232 Hospital E&M - Subsequent | Facility | 139 | 81 | $61.88 | $8,602 |
| 78452 Myocardial Perfusion Scan | Facility | 130 | 130 | $54.33 | $7,062 |
| 93000 Electrocardiogram | Office | 72 | 66 | $9.71 | $699 |
| 93356 Echocardiography (TTE/TEE) | Facility | 49 | 47 | $8.44 | $413 |
| 99215 Office E&M - Established | Facility | 46 | 37 | $113.13 | $5,204 |
| 93010 Electrocardiogram | Office | 45 | 45 | $6.04 | $272 |
By year: 2022 $301K for 8,834 services; 2023 $299K for 9,086 services; 2024 $307K for 9,588 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jagdish R Patel prescribed most often to Medicare patients was Metoprolol Tartrate, with 522 prescriptions and refills. In total Jagdish R Patel wrote 5,940 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Tartrate Generic | 522 | 1,417 | 149 | $3,924 |
| Eliquis Apixaban | 479 | 1,044 | 111 | $599K |
| Metoprolol Succinate Generic | 424 | 1,211 | 138 | $5,523 |
| Losartan Potassium Generic | 348 | 960 | 99 | $3,620 |
| Amlodipine Besylate Generic | 328 | 924 | 108 | $2,750 |
| Atorvastatin Calcium Generic | 315 | 852 | 95 | $3,346 |
| Furosemide Generic | 288 | 749 | 99 | $1,772 |
| Diltiazem Hcl Generic | 258 | 670 | 74 | $6,980 |
| Carvedilol Generic | 255 | 719 | 85 | $2,013 |
| Lisinopril Generic | 244 | 715 | 80 | $1,691 |
| Hydralazine Hcl Generic | 203 | 554 | 70 | $3,408 |
| Clopidogrel Clopidogrel Bisulfate | 172 | 486 | 53 | $2,024 |
| Xarelto Rivaroxaban | 148 | 355 | 36 | $192K |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | 134 | 378 | 42 | $2,875 |
| Spironolactone Generic | 130 | 328 | 40 | $939 |
Brand drugs: 817 claims; generic drugs: 5,123 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jagdish R Patel $23.74 ($23.74 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbott Laboratories with $23.74.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 1 | $23.74 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.